MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2

Tumor Biology

Volumn 36, Issue 5, 2015, Pages 3381-3387

  Huang, Ping ^a   Ye, Bo ^a   Yang, Yu ^a   Shi, Jianxin ^a   Zhao, Heng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Apoptosis; Bcl 2; Lung cancer; miR 181; NSCLC

Indexed keywords

MICRORNA; MICRORNA 181; PROTEIN BCL 2; UNCLASSIFIED DRUG; MIRN181 MICRORNA, HUMAN;

A549 CELL LINE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER STAGING; CANCER THERAPY; CANCER TISSUE; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER CELL LINE; MIGRATION INHIBITION; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL LUNG CARCINOMA; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; GENETICS; LUNG TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR INVASION; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; MICRORNAS; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84929955552     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2972-z     Document Type: Article

References (25)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA-Cancer J Clin. 2012;62:10–29.
2. Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer. 2006;6:449–58.
3. Van Rooij E, Purcell AL, Levin AA. Developing microRNA therapeutics. Circ Res. 2012;110:496–507.
4. Engels BM, Hutvagner G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene. 2006;25:6163–9.
5. Bartel DP. MicroRNAs genomics, biogenesis, mechanism and function. Cell. 2004;116:281–97.
6. Chitwood DH, Timmermans MC. Small RNAs are on the move. Nature. 2010;67:415–9.
7. Chen CZ. MicroRNAs as oncogenes and tumor suppressors. New Engl J Med. 2005;353:1768–71.
8. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010;466:835–40.
9. Dostie J, Mourelatos Z, Yang M, Sharma A, Dreyfuss G. Numerous microRNPs in neuronal cells containing novel microRNAs. RNA. 2003;9:180–6.
10. Ryan DG, Oliveira-Fernandes M, Lavker RM. Micro-RNAs of the mammalian eye display distinct and overlapping tissue specificity. Mol Vis. 2006;12:1175–84.
11. Naguibneva I, Ameyar-Zazoua M, Polesskaya A, Ait-Si-Ali S, Groisman R, Souidi M, et al. The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat Cell Biol. 2006;8:278–84.
12. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303:83–6.
13. Georgantas III RW, Hildreth R, Morisot S, Alder J, Liu C, Heimfeld S, et al. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci U S A. 2007;104:2750–5.
14. Ji J, Yamashita T, Budhu A, Jia H, Li C, Deng C, et al. Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology. 2009;50:472–80.
15. Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu Z, et al. Hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res. 2008;1236:185–93.
16. Bottoni A, Zatelli MC, Ferracin M, Tagliati F, Piccin D, Vignali C, et al. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J Cell Physiol. 2007;210:370–7.
17. Visone R, Rassenti LZ, Veronese A, Taccioli C, Costinean S, Aguda BD, et al. Karyotype specific microRNA signature in chronic lymphocytic leukemia. Blood. 2009;144:3872–9.
18. Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, et al. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother. 2010;64:399–408.
19. Zhu W, Shan X, Wang T, Shu YQ, Liu P. MiR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int J Cancer. 2010. doi:10.1002/ijc.25260.
20. Su H, Yang J, Xu T, Huang J, Xu L, Yuan Y, et al. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 2009;69:1135–42.
21. Bhatavdekar JM, Patel DD, Ghosh N, Chikhlikar PR, Trivedi TI, Suthar TP, et al. Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma. Dis Colon Rectum. 1997;40:785–90.
22. Merritt AJ, Potten CS, Watson AJ, Loh DY, Nakayama K, Hickman JA. Differential expression of Bcl-2 in intestinal epithelia correlation with ttenuationof apoptosis in colonic crypts and the incidence of colonic neoplasia. J Cell Sci. 1995;108:2261–71.
23. Hummel R, Hussey DJ, Haier J. MicroRNAs predictors and modifiers of chemo-and radiotherapy in different tumor types. Eur J Cancer. 2010;46:298–311.
24. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. Micro-RNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci. 2006;103:2257–61.
25. Mishra PJ, Merlino G. MicroRNA reexpression as differentiation therapy in cancer. J Clin Invest. 2009;119:2119–23.